HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
17.22
-0.34 (-1.94%)
Jul 2, 2024, 4:30 PM EDT - Market closed
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for HUTCHMED (China) stock have an average target of 29.7, with a low estimate of 17 and a high estimate of 50. The average target predicts an increase of 72.47% from the current stock price of 17.22.
Analyst Consensus: Buy
* Price targets were last updated on Nov 24, 2023.
Analyst Ratings
The average analyst rating for HCM stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +28.34% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -1.28% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +190.36% | Sep 5, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +190.36% | Jul 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | -7.08% | Aug 9, 2022 |
Financial Forecast
Revenue This Year
702.51M
from 838.00M
Decreased by -16.17%
Revenue Next Year
865.12M
from 702.51M
Increased by 23.15%
EPS This Year
-0.12
from 0.60
EPS Next Year
0.01
from -0.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 753.0M | 1.0B | 1.3B | 1.7B | 1.7B |
| Avg | 702.5M | 865.1M | 1.1B | 1.3B | 1.6B |
| Low | 608.7M | 766.4M | 907.2M | 1.0B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -10.1% | 43.1% | 51.2% | 55.6% | 29.0% |
| Avg | -16.2% | 23.1% | 23.3% | 24.5% | 16.7% |
| Low | -27.4% | 9.1% | 4.9% | -3.8% | -1.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.01 | 0.08 | 0.22 | 0.27 |
| Avg | -0.12 | 0.01 | 0.12 | 0.26 |
| Low | -0.23 | -0.07 | 0.05 | 0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -98.4% | - | 2,691.1% | 115.3% |
| Avg | - | - | 1,477.6% | 111.2% |
| Low | - | - | 520.2% | 100.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.